Ceftaroline-avibactam and comparator agents were tested by the broth microdilution method against 20,089 isolates consecutively collected in 2010 and 2011 from 75 U.S. medical centers. Ceftaroline-avibactam was active against Enterobacteriaceae (4,908 strains; MIC90, 0.25 μg/ml; highest MIC, 4 μg/ml), including meropenem-nonsusceptible Klebsiella spp. and ceftazidimenonsusceptible Enterobacter cloacae strains (MIC90, 1 μg/ml for both). Ceftaroline-avibactam was also active against ceftriaxone-nonsusceptible Streptococcus pneumoniae (MIC90, 0.25 μg/ml) and methicillin-resistant Staphylococcus aureus (MIC90, 1 μg/ml). Copyright © 2013, American Society for Microbiology. All Rights Reserved.
CITATION STYLE
Sader, H. S., Flamm, R. K., & Jones, R. N. (2013). Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. medical centers in 2010-2011. Antimicrobial Agents and Chemotherapy, 57(4), 1982–1988. https://doi.org/10.1128/AAC.02436-12
Mendeley helps you to discover research relevant for your work.